chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the booster shot she felt better, even better than she had in several years; After the booster shot she felt better, even better than she had in several years; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 11Oct2021 13:30 (Lot number: FC3181) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COPD" (unspecified if ongoing); "Myasthenia Gravis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, lot number EL9265), administration date: 27Jan2021, when the patient was 75 years old, for Covid-19 Immunisation, reaction(s): "had all kinds of infection with head and lung", "always running a low grade fever"; Bnt162b2 (Dose 2, lot number EN6198), administration date: 24Feb2021, when the patient was 75 years old, for Covid-19 Immunisation, reaction(s): "down again", "had low grade fever again". The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), PRE-EXISTING CONDITION IMPROVED (non-serious) all with onset Oct2021, outcome "unknown" and all described as "After the booster shot she felt better, even better than she had in several years". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Vaccination Facility Type: Pharmacy/Drug Store. List any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s): None. List all vaccines administered on same date with the Pfizer vaccine considered as suspect: None. AEs did not require a visit to Emergency Room or Physician Office.   Follow-up attempts are completed. No further information is expected.
As per CDC guidelines, avoid using two 50mg doses for infants weighing (?11 pounds), because 50mg doses should be reserved only for infants weighing (<11 pounds), for example those born during the season who will be at increased risk for severe RSV illness because of their young age. Furthermore, providers should be aware that some insurers may not cover the cost of two 50mg doses for an individual infant, and health care settings currently experiencing shortages of Beyfortus should prioritize 100mg doses to infants at the highest risk for severe RSV disease. Patient was monitored for 30 minutes after vaccines were administered and did not show any sign of pain, discomfort or adverse reaction. Patient tolerated administration well and was sent home.
p/vax pt in rt deltoid @ MD office;rt arm red, swollen, painful;dx superficial cellulitis rt upper arm;tx w/ice & amox;
Pt presents to Emergency seeking care for vaccine side effects. Pt recently received Moderna injection #1 from Pharmacy on 8.26/21 and presents with dizziness, double vision and multiple falls since her vaccination. Pt states adverse effects are getting worse and needs medical attention
The pt was vaccinated on 11/16/2001. Two days later she developed left shoulder, elbow and wrist joint pain. No reaction on the injection site. Pain above persists till present 01/23/2002.
53yo female received her first dose of Pfizer Covid vaccine on 4/22/21.  She had no other reaction to it and felt well until she awoke on 4/25/21, 3 days later, with vertigo worse with any movement, nausea/vomiting, inability to walk unattended.  She went to the ER where she had a normal CBC/d/p, BMP, sinus rhythm on monitor, MRI brain with COW/carotids, and MRV.  This was felt to be BPV- discharged with meclizine 25mg and proclorperazine 5mg.   I saw her in followup on 4/29/21 in the clinic and she was able to walk, was no longer vomiting, still had the "off" feeling with her balance but was improving.  Refilled meclizine.
3FEB97 inc temp, moist cough;6FEB97 cult positive Influenza A;
BODY ACHES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of body aches was not reported. This report was non-serious.
achiness day following injection; fever day following injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness day following injection) and PYREXIA (fever day following injection) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (achiness day following injection) and PYREXIA (fever day following injection). At the time of the report, PAIN (achiness day following injection) and PYREXIA (fever day following injection) outcome was unknown.            Concomitant and treatment medications were not provided. Adverse events were achiness and fever the day following the second vaccination.   This case was linked to MOD-2021-368836, MOD-2021-368930 (Patient Link).
pt recv vax 30JUN97 & some time p/vax pt exp a warm feeling, nausea & pressure in chest;the administering MD reported that believed pt to be hyperventilating;
I suffered relatively severe reaction to the 2nd Moderna dose:  Very sore arm for 4 or 5 days, several hours of chills 14 hours after the injection, and swollen lymph nodes, including an egg-sized lump under the left arm that persisted for a week.  However, the significant event was a seizure 10 days after the injection.  This was a first seizure with no prior history or obvious cause.   Seizure began while I was asleep.  Wife heard odd noises, couldn't wake me and called 911.  I woke up in an ER hours later.  Neurologist said the MRI was clear, but EEG showed unusual activity in the left temporal lobe.  Prescribed Keppra (ongoing) and speculated that the seizure might be related to aging. He thought the timing of the event 10 days after the CoViD vaccine was coincidental.  However, I am reporting it out of an abundance of caution.
Information has been received from a medical assistant referring to multiple unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VARIVAX (lot # L025208, expiration date 07-JUL-2017, lot # M004662, expiration date 27-JAN-2018, strength, dose, frequency and route were not reported). The vaccine has been stored under temperature of -10.6 degree for 30 hours. Data logger has been involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a pharmacist referring to a 67 year old male patient with no drug reactions/allergies. The patient's pertinent medical history was not reported. Concomitant therapies included thyroid medications, benzodiazepines and glaucoma medications (names of medications unspecified). On 19-NOV-2016, the patient received a dose of PNEUMOVAX23 lot # M038216 with expiration date of 09-MAY-2018 (strength, dose and dose number unknown) intramuscularly for immunization. Then, the patient left the pharmacy with no problem. However, about 15 minutes later, the patient came back to pharmacy complaining that he was having pain in his spine and he was not able to walk due to pain. The pharmacist asked the patient to stay in pharmacy so she could observe him. The patient was in the waiting area for about 20-30 minutes and he reported to pharmacist that he felt like his throat was little bit tight. The Pharmacist asked patient if he wanted to go to emergency room (ER) but the patient told pharmacist that he was not having any trouble breathing or shortness of breath but his throat felt little bit tight. The pharmacist continued to observe the patient and about 30 minutes after patient complained of tight throat, he reported to pharmacist that his throat was fine and his pain in spine was also subsiding. No treatment was given for the events. The patient eventually felt completely fine and was able to walk and went home. No product quality complaint (PQC) was involved. The relationship between the events and PNEUMOVAX23 was not provided. Upon internal review, the event of unable to walk was determined to be medically significant. Additional information has been requested.
chest pressure; trouble breathing/out of breath; strong allergy that's nasal related, and it feels like asthma; inflammation in the airway; he received it 2 days before the deadline; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTRATION ERROR (he received it 2 days before the deadline), CHEST DISCOMFORT (chest pressure), DYSPNOEA (trouble breathing/out of breath), RHINITIS ALLERGIC (strong allergy that's nasal related, and it feels like asthma) and INFLAMMATION (inflammation in the airway) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asthma and Wisdom teeth removal. Concurrent medical conditions included Injury (medical uses for his previous injury). Concomitant products included CANNABIS SATIVA (MARIJUANA) for Injury.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced PRODUCT ADMINISTRATION ERROR (he received it 2 days before the deadline). On an unknown date, the patient experienced CHEST DISCOMFORT (chest pressure), DYSPNOEA (trouble breathing/out of breath), RHINITIS ALLERGIC (strong allergy that's nasal related, and it feels like asthma) and INFLAMMATION (inflammation in the airway). The patient was treated with ALBUTEROL [SALBUTAMOL] ongoing since an unknown date for Inflammation and Nasal allergy, at an unspecified dose and frequency. At the time of the report, PRODUCT ADMINISTRATION ERROR (he received it 2 days before the deadline) had resolved and CHEST DISCOMFORT (chest pressure), DYSPNOEA (trouble breathing/out of breath), RHINITIS ALLERGIC (strong allergy that's nasal related, and it feels like asthma) and INFLAMMATION (inflammation in the airway) outcome was unknown.            Patient visited doctor for his strong allergy and an electrocardiogram (ECG) was performed on an unspecified date. The doctor told that the patient had some inflammation the airway. The patient was not diagnosed with asthma. The patient was also prescribed an unspecified steroid for a week.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. Concurrent conditions and medical history were not provided. On 15-APR-2015, the patient was vaccinated with an expired dose of PNEUMOVAX 23 "25/0.5" injection, lot # J005071 and expiration date 19-JAN-2015 (dose and route of administration were not provided). No adverse effect was reported. The concomitant medication was not provided. This is one of two reports received from the same reporter. Additional information has been requested.
Pt, am 11 year old female, received DTaP on 03/14/07, instead of Tdap. Tdap was ordered by MD. No adverse events.
This spontaneous report was received from a nurse refers to a 6 months old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 30-AUG-2017, the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # M044397, expiry date: 20-JUN-2018) orally for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007014.
High fever for two days (102-103 deg F). Never had any reaction to previous flu vaccinations, or any other vaccines). Back to normal after two days.
Patient received Pfizer Covid-19 Vaccine dose #1 after BUD-expiration date. Doctor recommendation is for patient to be revaccinated. Patient's parents were informed of the adverse event and Doctor recommendations.  No symptoms or sign were reported by parents in reference to this event.
Patient was given Dtap INFANRIX vaccine instead of a Td TENIVAC. Reached out to health department for advice. Was advised to not repeat Tetanus injection. Will inform patient.
Patient reports approximately 24 hours after the second Pfizer COVID-19 vaccination she developed vomiting with fever for approximately 48 hours, reports she was sitting in a rocking chair, attempted to stand up but fell due to muscle weakness. she was unable to stand, could not lift her legs, required her husband to lift her, then developed urinary incontinence and upper extremity weakness. she did not have difficulty breathing. she did not go to the hospital and reported this today during a routine visit. symptoms resolved approximately 3 days later.
Hyper Blood Pressure 128/64 before Vaccine first of 11/22. After Vaccine jump up to 190/90. Same time as blood pressure jump clumps of Hair turn gray overnight and fell out next in clumps and has continued since 12/27/22. My hair was always dark Brown and No Hair loss in family history, not even male pattern baldness. 4 brothers younger and older still have thick brown hair. Massive Head Aches night and day until change of blood pressure medicine but still in high 170's and 86
Myalgia, Arthralgia, Fever, CHILLS, SWOLLEN LYMPH NODE "BASEBALL-SIZE" LEFT AXILLA,FATIGUE Narrative:
Information has been received from a registered nurse concerning a 7 year old male child who on 3/28/96 was vaccinated with a dose of varicella virus vaccine live (lot # 612214/1124B). On 12/4/03, yesterday, the patient broke out in a mild case of chicken pox. Unspecified medical attention was sought. There was no product quality complaint involved. It was noted that this case was part of 16 cases of chicken pox reported at a school, 4 of which had been previously vaccinated with varicella virus vaccine live. The reporter also mentioned three other children who were siblings and experienced similar reactions. Additional information has been requested.
sore arm; diarrhea; bad taste in her mouth/can taste vaccine in her mouth and throat; This is a spontaneous report from a contactable consumer (patient). This 67-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot#: EL1283), via an unspecified route of administration on 26Jan2021 09:55 at single dose in the left arm for COVID-19 vaccination. Medical history and concomitant medications were none. Patient got her first injection of the COVID-19 vaccine on 26Jan2021 at 09:55AM in her left arm. Patient said that the diarrhea just started on 26Jan2021, she had tried calling earlier and had to hang up because of it, maybe because she was nervous. Patient said that she tasted the vaccine constantly, she has been experiencing a bad taste in her mouth, she couldn't stand the taste. Patient couldn't get rid of the taste. She said beforehand she was scared of anaphylactic shock, but she was having the taste in her mouth and diarrhea. She said she had the taste of the vaccine in her mouth and throat on 26Jan2021. She said that everything that she eats she is trying to get taste out of her throat. Patient has done no treatment yet for the diarrhea or the taste in her mouth. She said that her arm didn't hurt afterwards and she didn't feel the shot, and now she can't touch her arm without it hurting though she has been moving her arm a lot. She said she knew that from the flu shot, but that never hurt her, this thing was sore (sore arm) on 26Jan2021. She said she wasn't worried about that though, she just wanted to know if the taste would go away, and if it was normal. She said that there was nothing that said anything about diarrhea either, and she was not sick, she didn't feel sick, there was just the taste. Outcome of the events was unknown.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 29-MAY-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N020353 and expiration date 28-APR-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709:
Six hours post-vax the patient developed a diffuse erythematous, urticaria, pruriticl rash over his entire body. The patient was treated with Benadryl.
At time of injection I felt pain in arm which  I normally do not feel.  Shortly thereafter my upper arm and shoulder started hurting. The arm was difficult to raise and painful to move.  Eventually the severe pain subsided over a weeks time. The ache in the upper arm and shoulder persisted. As of today the arm becomes weak when raised above 90 degrees to lift anything.  A constant ache of upper arm and shoulder is continuous when at rest. I golf a lot and my arm hurts 2/3 of the way into my backswing and often impedes my ability to complete a swing. I have not sought treatment but did report to my general practitioner  about 2 weeks after my injection. He advised Tylenol which i did not take.
I received my 2nd booster shot on 07/07/2022 and my adverse event on 07/09/2022 vertigo; my left arm was sore. Soreness of the arm lasted till yesterday. My vertigo is still on going. My doctor did a positional vertigo. She also told me that I have to go to see a therapist it could be could of sessions. They don't know how long its going to be there for.
Patient came in after article in newspaper shared that the HIGH DOSE FLU vaccine caused persistent arm pain this year. She said he had arm pain since receiving the vaccine.
Weak; Voice was slightly hoarse; Tired; Head hurt like it was about to explode; Nauseous; Dizzy; Right eye got blurry; Thought she was getting a vertigo attack; Breathing was slightly affected; This spontaneous case was received on 02-Oct-2020, from other non-health professional via Health Authority (reference number: SEQW20-02848) and concerned a 62-year old, female patient.  The patient's medical history included asthma, and vertigo. The patient's concomitant medications included Meclizine (meclozine) for vertigo.  On 02-Oct-2020, at 1 pm, patient was vaccinated with unspecified Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose, route of administration, anatomical location: not reported) for prevention of seasonal influenza. The batch number was not reported.  On the same day, at 4 pm, the patient felt nauseous and dizzy and her head hurt like it was about to explode. Her right eye got blurry around this time. The patient took medizine for vertigo and thought she was getting a vertigo attack, but the medication did not help. The patient also felt that her breathing was slightly affected but was not sure if asthma was the cause.   On unspecified date, the patient recovered from the events, but she was still feeling tired, weak and her voice was slightly hoarse.  At time of initial reporting on 02-Oct-2020, the patient was recovering from the events tired, weak and 'hoarse voice'.  The reporter stated that was unsure if this was the vaccine that caused her issues or if "maybe it just happened to her, she was the oddball".  The reporter assessed the case as non-serious.  Company comment: A 62-year old, female patient was administered Flucelvax QIV vaccine. The patient developed nausea, dizziness, headache, vertigo, dyspnoea, asthenia, fatigue and vision blurred after receiving vaccine. The patient's medical history included asthma, and vertigo. The patient's concomitant medications included Meclizine for vertigo. Causality was confounded for the events of vertigo and dyspnoea, however, cannot be totally excluded and is assessed as unlikely related. (defaults to "related" in the safety database for reporting purposes). For all remaining events, causality is assessed as possibly related due to plausible chronology.; Reporter's Comments: The reporter stated that was unsure if this was the vaccine that caused her issues or if "maybe it just happened to her, she was the oddball".; Sender's Comments: A 62-year old, female patient was administered Flucelvax QIV vaccine. The patient developed nausea, dizziness, headache, vertigo, dyspnoea, asthenia, fatigue and vision blurred after receiving vaccine. The patient's medical history included asthma, and vertigo. The patient's concomitant medications included Meclizine for vertigo. Causality was confounded for the events of vertigo and dyspnoea, however, cannot be totally excluded and is assessed as unlikely related. (defaults to "related" in the safety database for reporting purposes). For all remaining events, causality is assessed as possibly related due to plausible chronology.
Initial misuse report received from a Healthcare professional on 06 January 2014. A 4-year-old patient had received first dose of 0.25 ml of FLUZONE last year. No adverse event was reported. Documents held by sender: none.
pt started last noc w/chills, aches, phlegm build up causing vomiting;pt stated had a similar rxn last year from flu shot;
For 1.5 days: had headache, body aches especially legs, fever, severe chills, sweats, fatigue, and severe right arm pain throbbing and unable to use or move it. For 3 days: severe right arm pain and unable to move or use. Ongoing: still having right arm pain and tightness as well as restricted movement.
On 4/21/2021 became very lethargic with vital signs of BP 99/48, Pulse 112, Temp 101.8. Medical Director notified and patient was transferred to ER for evaluation via ambulance. Discharge summary from hospital shows acute encephalopathy suspect toxic effect from Moderna vaccine and fever after Moderna  vaccination.